Curaleaf Holdings Inc
TSX:CURA

Watchlist Manager
Curaleaf Holdings Inc Logo
Curaleaf Holdings Inc
TSX:CURA
Watchlist
Price: 1.15 CAD -7.26% Market Closed
Market Cap: 867.9m CAD

Intrinsic Value

The intrinsic value of one CURA stock under the Base Case scenario is 3.05 CAD. Compared to the current market price of 1.15 CAD, Curaleaf Holdings Inc is Undervalued by 62%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CURA Intrinsic Value
3.05 CAD
Undervaluation 62%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Curaleaf Holdings Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CURA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CURA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Curaleaf Holdings Inc
TSX:CURA
US
Pharmaceuticals
Market Cap
869.9m CAD
IPO
Oct 22, 2015
US
Pharmaceuticals
Market Cap
869.9m CAD
IPO
Oct 22, 2015
Price
CA$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Curaleaf Holdings Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Curaleaf Holdings Inc

Current Assets 445.9m
Cash & Short-Term Investments 121.9m
Receivables 65.9m
Other Current Assets 258.2m
Non-Current Assets 2.5B
Long-Term Investments 1.7m
PP&E 767.6m
Intangibles 1.7B
Other Non-Current Assets 31.8m
Efficiency

Free Cash Flow Analysis
Curaleaf Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Curaleaf Holdings Inc

Revenue
1.7B USD
Cost of Revenue
-858.4m USD
Gross Profit
794.4m USD
Operating Expenses
-766.4m USD
Operating Income
28m USD
Other Expenses
-304.5m USD
Net Income
-276.5m USD
Fundamental Scores

CURA Profitability Score
Profitability Due Diligence

Curaleaf Holdings Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
32/100
Profitability
Score

Curaleaf Holdings Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

CURA Solvency Score
Solvency Due Diligence

Curaleaf Holdings Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Positive Net Debt
26/100
Solvency
Score

Curaleaf Holdings Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CURA Price Targets Summary
Curaleaf Holdings Inc

Wall Street analysts forecast CURA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CURA is 4.18 CAD with a low forecast of 1.62 CAD and a high forecast of 6.3 CAD.

Lowest
Price Target
1.62 CAD
41% Upside
Average
Price Target
4.18 CAD
264% Upside
Highest
Price Target
6.3 CAD
448% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Curaleaf Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CURA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one CURA stock?

The intrinsic value of one CURA stock under the Base Case scenario is 3.05 CAD.

Is CURA stock undervalued or overvalued?

Compared to the current market price of 1.15 CAD, Curaleaf Holdings Inc is Undervalued by 62%.

Back to Top